Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Prado, W A
De Rossi, C
Garrigues, T M
Guterres, S S
Pohlmann, A R
Beck, R C R
Schaefer, U F
MetadataShow full item record
AbstractThe treatment of various hair disorders has become a central focus of good dermatologic patient care as it affects men and women all over the world. For many inflammatory-based scalp diseases, glucocorticoids are an essential part of treatment, even though they are known to cause systemic as well as local adverse effects when applied topically. Therefore, efficient targeting and avoidance of these side effects are of utmost importance. Optimizing the balance between drug release, interfollicular permeation, and follicular uptake may allow minimizing these adverse events and simultaneously improve drug delivery, given that one succeeds in targeting a sustained release formulation to the hair follicle. To test this hypothesis, three types of polymeric nanocarriers (nanospheres, nanocapsules, lipid-core nanocapsules) for the potent glucocorticoid clobetasol propionate (CP) were prepared. They all exhibited a sustained release of drug, as was desired. The particles were formulated as a dispersion and hydrogel and (partially) labeled with Rhodamin B for quantification purposes. Follicular uptake was investigated using the Differential Stripping method and was found highest for nanocapsules in dispersion after application of massage. Moreover, the active ingredient (CP) as well as the nanocarrier (Rhodamin B labeled polymer) recovered in the hair follicle were measured simultaneously, revealing an equivalent uptake of both. In contrast, only negligible amounts of CP could be detected in the hair follicle when applied as free drug in solution or hydrogel, regardless of any massage. Skin permeation experiments using heat-separated human epidermis mounted in Franz Diffusion cells revealed equivalent reduced transdermal permeability for all nanocarriers in comparison to application of the free drug. Combining these results, nanocapsules formulated as an aqueous dispersion and applied by massage appeare to be a good candidate to maximize follicular targeting and minimize drug penetration into the interfollicular epidermis. We conclude that such nanotechnology-based formulations provide a viable strategy for more efficient drug delivery to the hair follicle. Moreover, they present a way to minimize adverse effects of potent glucocorticoids by releasing the drug in a controlled manner and simultaneously decreasing interfollicular permeation, offering an advantage over conventional formulations for inflammatory-based skin/scalp diseases.
CitationNanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects. 2016, 223:207-14 J Control Release
AffiliationHelmholtz Institute for Pharmaceutical Research Saarland (HIPS);Saarland University, Building A4.1, 66123 Saarbruecken, Germany.
The following license files are associated with this item:
- Chromatographic method for clobetasol propionate determination in hair follicles and in different skin layers.
- Authors: Ângelo T, Cunha-Filho MS, Gelfuso GM, Gratieri T
- Issue date: 2017 Feb
- Nanoencapsulation of Clobetasol Propionate Decreases Its Penetration to Skin Layers Without Changing Its Relative Skin Distribution.
- Authors: de Andrade DF, Fontana MC, Pohlmann AR, Guterres SS, Carlos R, Beck R
- Issue date: 2015 Jan
- The in vitro use of the hair follicle closure technique to study the follicular and percutaneous permeation of topically applied drugs.
- Authors: Stahl J, Niedorf F, Wohlert M, Kietzmann M
- Issue date: 2012 Mar
- Improved efficacy in the treatment of contact dermatitis in rats by a dermatological nanomedicine containing clobetasol propionate.
- Authors: Fontana MC, Rezer JF, Coradini K, Leal DB, Beck RC
- Issue date: 2011 Oct
- Clobetasol-loaded nanostructured lipid carriers for epidermal targeting.
- Authors: Silva LA, Andrade LM, de Sá FA, Marreto RN, Lima EM, Gratieri T, Taveira SF
- Issue date: 2016 Jun